Evidence map›Paper›PMID 38839920›Full record

ArticleNPJ digital medicine2024

Deployment and validation of the CLL treatment infection model adjoined to an EHR system.

Rudi Agius, Anders C Riis-Jensen, Bettina Wimmer, Caspar da Cunha-Bang, Daniel Dawson Murray, Christian Bjorn Poulsen, Marianne B Bertelsen, Berit Schwartz, Jens Dilling Lundgren, Henning Langberg and 1 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rudi AgiusDepartment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Anders C Riis-JensenSP Sundhedsdata, The Data Unit, Capital Region of Denmark, Copenhagen, Denmark.
Bettina WimmerSP Sundhedsdata, The Data Unit, Capital Region of Denmark, Copenhagen, Denmark.ORCID http://orcid.org/0009-0002-7229-950X
Caspar da Cunha-BangDepartment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Daniel Dawson MurrayCenter of Excellence for Health, Immunity, and Infections (CHIP), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Christian Bjorn PoulsenDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark.ORCID http://orcid.org/0000-0001-9785-1378
Marianne B BertelsenSP Sundhedsdata, The Data Unit, Capital Region of Denmark, Copenhagen, Denmark.
Berit SchwartzRigshospitalets Innoovationscenter, Copenhagen University Hospital Rigshopsitalet, Copenhagen, Denmark.
Jens Dilling LundgrenCenter of Excellence for Health, Immunity, and Infections (CHIP), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-8901-7850
Henning LangbergRigshospitalets Innoovationscenter, Copenhagen University Hospital Rigshopsitalet, Copenhagen, Denmark.
Carsten Utoft NiemannDepartment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. carsten.utoft.niemann@regionh.dk.ORCID http://orcid.org/0000-0001-9880-5242

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research algorithms are seldom externally validated or integrated into clinical practice, leaving unknown challenges in deployment. In such efforts, one needs to address challenges related to data harmonization, the performance of an algorithm in unforeseen missingness, automation and monitoring of predictions, and legal frameworks. We here describe the deployment of a high-dimensional data-driven decision support model into an EHR and derive practical guidelines informed by this deployment that includes the necessary processes, stakeholders and design requirements for a successful deployment. For this, we describe our deployment of the chronic lymphocytic leukemia (CLL) treatment infection model (CLL-TIM) as a stand-alone platform adjoined to an EPIC-based Danish Electronic Health Record (EHR), with the presentation of personalized predictions in a clinical context. CLL-TIM is an 84-variable data-driven prognostic model utilizing 7-year medical patient records and predicts the 2-year risk composite outcome of infection and/or treatment post-CLL diagnosis. As an independent validation cohort for this deployment, we used a retrospective population-based cohort of patients diagnosed with CLL from 2018 onwards (n = 1480). Unexpectedly high levels of missingness for key CLL-TIM variables were exhibited upon deployment. High dimensionality, with the handling of missingness, and predictive confidence were critical design elements that enabled trustworthy predictions and thus serves as a priority for prognostic models seeking deployment in new EHRs. Our setup for deployment, including automation and monitoring into EHR that meets Medical Device Regulations, may be used as step-by-step guidelines for others aiming at designing and deploying research algorithms into clinical practice.

Identifiers

PMID38839920
PMCPMC11153589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.